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Abstract 11 
 12 
Amphipathic pH-responsive polymers have shown to increase the permeability of cell 13 
membranes to trehalose hence improving the cryopreservation of mammalian cells. 14 
However, the trafficking of both the polymer and trehalose across the cell membrane has not 15 
yet been thoroughly analysed. The objective of this study was to investigate the effect on 16 
cryopreservation of the trafficking of the disaccharide trehalose along PP-50, an amphipathic 17 
polymer, through an osteosarcoma cell line (SAOS-2). Confocal microscopy analysis 18 
confirmed the presence of intracellular labelled trehalose only when incubated in the 19 
presence of PP-50. Further analysis confirmed that both trehalose and PP-50 localised in 20 
the cytoplasm, accumulated mainly in the perinuclear area. Quantitative analysis of the 21 
colocalisation between trehalose and PP-50 showed Pearson and Manders coefficients of 22 
0.862 ± 0.008 and 0.766 ± 0.033, respectively, suggesting a high degree of intracellular 23 
colocalisation between these molecules. Cryopreserved cells pre-incubated with trehalose 24 
and PP-50 showed increased cryosurvival when compared with cells pre-incubated in the 25 
absence of the polymer. PP-50 showed to be directly involved in the uptake of trehalose, a 26 
critical characteristic towards use in cryopreservation and biomedical applications. 27 
 28 
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1. Introduction 33 
 34 
Recent developments in tissue engineering, recombinant DNA technologies and 35 
biopharmaceutical production have increased the importance of living cells for clinical 36 
medical care. The establishment of these areas in the past several decades has made it 37 
possible for the development of numerous therapeutic proteins and treatments to address a 38 
corresponding variety of unmet medical needs [1].  39 
 40 
Major advances in these areas are frequently limited by the lack of understanding of long-41 
term cryostorage of cells [2]. Cryopreservation of cell lines is a technically challenging 42 
process leading to persistent failures in terms of poor revival rate and atypical cell properties. 43 
Currently, no single cryopreservation method has been universally applied with variations in 44 
techniques applied depending on the facility and aim of use [3,4].  45 
 46 
Cells normally require cryoprotective agents (CPAs) to survive long-term storage at low 47 
temperatures [5]. Cryoprotectants are essential additives to cell concentrates able to inhibit 48 
the formation of intra and extracellular crystals and hence cell death [3,6,7]. Successful 49 
cryopreservation of mammalian cells involves high CPAs concentrations and their toxicity 50 
has been recognized as a critical barrier to further progress in the field [5,8].  51 
 52 
Dimethyl sulfoxide (Me2SO) is the standard cryoprotectant used to prevent freezing damage 53 
to living cells. Whilst the effectiveness of Me2SO as a cryoprotectant is generally improved 54 
with increasing concentration, its toxicity to cells is both time and temperature dependent 55 
and has been thoroughly documented [9,10]. Serious adverse reactions have also been 56 
reported related to cardiovascular, respiratory and renal systems [3,11]. On the other hand, 57 
foetal bovine serum (FBS) is an essential component in cryopreservation media, although 58 
presents many challenges for the pharmaceutical industry since its usage involves both 59 
moral and scientific problems. In clinical applications the use of reagents of animal origin is 60 
undesirable due to potential transmission of animal pathogens and the risk of developing 61 
antibodies against FBS, leading to rejection of the transfused cells [12]. Because of the 62 
safety risks involved, regulatory authorities discourage the use of FBS for the production of 63 
biological products for human use [13]. Hence, significant interest exists in the development 64 
of non-toxic cryopreservation agents and cryopreservation techniques. Studies over the last 65 
30 years have explored a variety of cryoprotective agents. Most attention has focused on the 66 
role of sugars in mammalian cells, predominantly the disaccharide trehalose [14].  67 
 68 
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Non-permeating sugars are important ingredients in a vast number of cryopreservation 69 
protocols. Sugars help in the dehydration of cells by increasing osmolarity, in addition to 70 
preserving structural integrity. They also function as an osmotic buffer, reducing osmotic 71 
shock by decreasing the speed and amount of cell swelling [15]. Although monosaccharides 72 
can transit across animal cell membranes, disaccharides cannot [16]. This issue is crucial 73 
when high intracellular concentrations of disaccharides such as trehalose are needed for 74 
viable cryopreservation [2,5].  75 
 76 
To overcome this barrier, different methods have been used to increase intracellular 77 
disaccharides levels, such as the use of ATP receptor channels or engineered membrane 78 
pores [2,17,18]. Disadvantages of these alternatives include the induction of cell death by 79 
either necrosis or apoptosis, amongst others [19]. 80 
 81 
One successful method to induce disaccharide transport into cells includes the use of 82 
amphipathic biodegradable pH-responsive polymers given their ability to permeate cell 83 
membranes and biocompatibility [20–22]. These polymers were developed to mimic the 84 
membrane permeabilising activity of viral and bacterial peptides [23]. Typically, they go 85 
through a conformational change from extended charged chains to aggregated hydrophobic 86 
structures as the environmental pH drops below their pKa, thus interacting with the 87 
hydrophobic interior of phospholipid bilayers. This facilitates increased membrane 88 
permeability by pore formation or by increasing membrane solubilisation [24,25].  89 
 90 
Recent studies have shown the impact of PP-50, a biopolymer consisting of poly(L-lysine 91 
iso-phthalamide) grafted with the hydrophobic amino acid L-phenylalanine, on increased 92 
post-thaw viabilities of cryopreserved red blood cells and osteosarcoma cells [26,27]. 93 
Despite its successful use in cryopreservation in previous studies, trehalose uptake 94 
mediated by PP-50 has not been studied in depth. In this work, the effect of PP-50 on 95 
trehalose transport was evaluated in osteosarcoma cells, a model for adherent cells, to 96 
provide key information regarding this amphipathic biopolymer towards use in 97 
cryopreservation and other clinical applications.  98 
 99 
2. Materials and methods 100 
 101 
2.1. Materials 102 
 103 
The SAOS-2 cells were obtained from the European Collection of Cell Cultures. Dulbecco’s 104 
modified Eagle’s medium (DMEM), foetal bovine serum (FBS), L-glutamine, penicillin, trypan 105 
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blue, and streptomycin were purchased from Invitrogen (UK). Me2SO and sodium hydroxide 106 
(NaOH) were purchased from ThermoFisher (UK). Phosphate-Buffered Saline (PBS), 107 
trypsin–EDTA, Alexa Fluor 647 cadaverin were purchased from Life Technologies™ (UK). 108 
N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (EDC), N-hydroxysuccinimide 109 
(sulfo-NHS), Hoechst H33342, propidium iodide, and trehalose were obtained from Sigma-110 
Aldrich (UK). The CellTiter 96® AQueous One Solution Cell Proliferation Assay (MTS) was 111 
obtained from Promega (UK). Visking tubing was purchased from Medicell Membranes Ltd. 112 
(UK). FITC-labelled trehalose was trehalose was produced by the Davis Group, University of 113 
Oxford (UK) [28]. All chemicals and biochemicals used were of analytical grade.  114 
 115 
2.2. PP-50 synthesis 116 
 117 
The synthesis and characterisation of the PP-50 polymer were as previously described by 118 
Lynch et al. [26]. PP-50 consists of a poly(L-lysine iso-phthalamide) backbone grafted with L-119 
phenylalanine at a degree of grafting of 46.2% (Mn = 23.0 kDa).  120 
 121 
2.2.1. PP-50/AF647 synthesis 122 
 123 
The conjugation of AF647 cadaverine to PP-50 was achieved by standard EDC/sulfo-NHS 124 
amide reaction [29]. The product was purified by dialysis against water in Visking tubing 125 
(MW cut-off 3,500 Da) and lyophilised using a Fisher Scientific Heto LyoLab3000 (UK) to 126 
yield a blue solid powder. 127 
 128 
PP-50/AF647 was analysed by using attenuated total reflectance FTIR (ATR-FTIR) 129 
spectroscopy to determine whether PP-50 were successfully conjugated with Alexa Fluor 130 
647 cadaverine. Spectra were collected using a Thermo Nicolet Nexus 870 spectrometer 131 
(Waltham, MA, USA) as the average of 32 scans with a wavenumber resolution of 4 cm-1 in 132 
the 600-4000 cm-1 range. 133 
 134 
2.3. Cell culture 135 
 136 
SAOS-2 osteosarcoma cells were cultured in growth media consisting of DMEM with FBS 137 
(10% v/v), L-glutamine (2 mM), penicillin (100 IU/ml), and streptomycin (100 µg/ml) in 75 cm2 138 
flasks supplied by Corning (UK). Cells were incubated at 37 °C with 5 % of CO 2. At 70% 139 
confluence, cells were washed twice with PBS, then subcultured with trypsin (0.05% w/v) 140 
and EDTA (0.02% w/v) and subsequently replated for further expansion or experiments.  141 
 142 
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2.4. Trehalose uptake mediated by PP-50 143 
 144 
Cells were seeded on 1.8 cm2 chambered cell culture cover glasses (Nunc, UK) at a density 145 
of 3 x 104 cells/well and grown for 24-48 hours. Cells were then incubated with 50 mM FITC-146 
trehalose in the presence or absence of 250 µg/ml PP-50 for 2, 4, and 6 hours. FITC-147 
trehalose and PP-50 solutions were prepared in DMEM. Cells were washed twice with PBS 148 
and extracellular labelled molecules were quenched using 0.4 % trypan blue [30]. Cells were 149 
washed again with PBS and left in growth media. Cells were incubated for 15 minutes with 5 150 
µg/ml PI and 5 µg/ml H33342 then incubated in growth media and analysed using a TCS 151 
SP5 inverted laser scanning microscope (Leica, Germany). An argon laser was used to 152 
visualise FITC-trehalose (emission at 488 nm and an emission filter set at 505-555 nm). To 153 
visualise propidium iodide, a helium neon laser was used (emission at 633 nm and emission 154 
filter set at 650-700 nm). H33342 stained nuclei were excited using a diode laser emitting at 155 
405 nm. Images were taken sequentially. 156 
 157 
2.5. Colocalisation of labelled PP-50 with labelled trehalose 158 
 159 
Cells were assessed using 250 µg/ml PP-50/AF647 and 50 mM FITC-trehalose after 4 hours 160 
of incubation. In addition, the permeable dye Hoechst 33342 (5 µg/ml) was used to evaluate 161 
the nuclear morphology of cells. Cells were placed on 1.8 cm2 chambered cell culture cover 162 
glasses (Nunc, UK) at a density of 3 x 104 cells and imaged using a TCS SP5 inverted laser 163 
scanning microscope (Leica, Germany). To visualise PP-50/AF647, a helium neon laser was 164 
used (emission at 633 nm and emission filter set at 650-700 nm). Images were taken 165 
sequentially. 166 
 167 
2.6. Image analysis  168 
 169 
Fluorescent images of cells incubated with labelled trehalose in the presence of labelled PP-170 
50 were acquired using the appropriate wavelengths for each molecule, as explained above. 171 
Images were then merged and converted to 8 bit RGB images using ImageJ software. 172 
Analysis with the JACoP plugin provided Pearson’s and Manders' overlap coefficient.  173 
 174 
2.7. Cryopreservation using PP-50 175 
 176 
SAOS-2 cells were seeded into 6-well plate culture dishes at 3 x 105 cells/well. Once cells 177 
reached 75% confluence, they were washed twice with PBS and incubated in one of the 178 
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following solutions: 1) 100 % (v/v) DMEM containing 200 mM trehalose with and without 250 179 
µg/ml PP-50; 2) 90 % (v/v) DMEM and 10 % (v/v) FBS containing 200 mM trehalose with 180 
and without 250 µg/ml PP-50. All DMEM solutions were supplemented with L-glutamine, 181 
penicillin, and streptomycin at a pH of 7.05. After 4 hours of incubation, treated cells were 182 
washed twice with PBS and 200 µl/well of trypsin/EDTA was added. Cells were then 183 
incubated for 5 minutes and centrifuged at 350 g for 5 minutes. Each pellet was then 184 
resuspended with 1 ml of a solution of 90 % (v/v) FBS and 10 % (v/v) DMEM. Control cells 185 
were resuspended in two different solutions; 100 % (v/v) DMEM was used as a negative 186 
control C(-) for cryosurvival, whereas 90 % (v/v) FBS with 10 % (v/v) Me2SO was used as a 187 
positive control C(+). All samples were transferred to cryovials and placed into freezing 188 
containers at -80 °C for 48 hours and then stored i n liquid nitrogen for 72 hours.  189 
 190 
Individual vials were thawed in a 37 °C water bath with continuous and mild agitation for 5 191 
min. Viability was firstly determined by the trypan blue exclusion method using a cell counter 192 
[31]. Cells negative for trypan blue were considered live and those stained blue were 193 
considered dead. Viable cells were also determined using the CellTiter 96® AQueous One 194 
Solution Cell Proliferation Assay according to the manufacturer’s instructions. Briefly, the 195 
MTS assay was performed in 96-well plates by adding 20 µL of 3-(4,5-dimethylthiazol-2-yl)-196 
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium salt to the cells [32,33]. Cells 197 
were then incubated for 1 hour at 37 °C. Absorbance  was then measured at 490 nm using a 198 
96-well plate reader (BMG Labtech, UK) to determine the formazan concentration, which is 199 
proportional to the number of living cells. Absorbance was corrected by subtraction of 200 
background absorbance. Data was normalised to the positive freezing control C(+).  201 
 202 
2.8. Statistical analysis 203 
 204 
All measurements were carried out in three independent replicates. Results were analysed 205 
using a one-way ANOVA followed by a Tukey’s test for multiple comparisons. The tests were 206 
analysed using GraphPad Prism (GraphPad Software, US). The difference was considered 207 
statistically significant when p < 0.05. 208 
 209 
3. Results 210 
 211 
3.1. Trehalose uptake mediated by PP-50 212 
 213 
The effect on trehalose uptake when incubated with PP-50 was investigated using confocal 214 
microscopy (Fig. 1). Cells were incubated with FITC-trehalose in the presence and absence 215 
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of PP-50 for 2, 4 and 6 hours. As seen in Fig. 1, intracellular labelled trehalose (green 216 
fluorescence) was seen only when incubated in the presence of PP-50. In addition, a direct 217 
correlation was found between intracellular labelled trehalose and incubation time. Cells 218 
displayed normal nuclei features, shown by the staining with Hoechst H33342 (blue 219 
fluorescence), and high viability, shown by the lack of propidium staining (red fluorescence). 220 
 221 
3.2. Colocalisation of labelled PP-50 with labelled trehalose 222 
 223 
The colocalisation of PP-50 with trehalose was analysed by confocal microscopy (Fig. 2). 224 
Cells were incubated with PP-50/AF647 (red fluorescence) and FITC-trehalose (green 225 
fluorescence) for a period of 4 hours. The colocalisation of these molecules is shown in 226 
yellow. As seen in the figure, osteosarcoma cells incorporated intracellularly both labelled 227 
PP-50 and trehalose. Both molecules appeared in the cytoplasm, located mainly in the 228 
perinuclear space. A high degree of colocalisation was observed between the polymer and 229 
trehalose. Cells also displayed normal nuclei features, shown by the staining with Hoechst 230 
H33342. 231 
 232 
3.3. Image analysis of PP-50 colocalisation with trehalose 233 
 234 
The analysis of the colocalisation of labelled PP-50 with labelled trehalose was assessed 235 
using ImageJ software and at least 5 independent images. The Pearson (PC) and Manders 236 
(M1) overlap coefficients were derived with the JaCoP ImageJ tool. The PC and M1 237 
coefficients were 0.862 ± 0.008 and 0.766 ± 0.033, respectively. 238 
 239 
3.4. Cryopreservation using PP-50  240 
 241 
To evaluate the effect of trehalose uptake mediated by PP-50 on cryopreservation, 242 
osteosarcoma cells were pre-incubated with trehalose, FBS or a combination of both 243 
molecules in the presence and absence of PP-50, and then cryopreserved (Fig. 3). Trypan 244 
blue staining and the MTS assay were used to measure viability immediately post-thaw, i.e. 245 
cryosurvival. As shown by both assays, a higher cryosurvival was observed when cells were 246 
incubated in the presence of PP-50 for all pre-freezing incubation media. The largest 247 
cryosurvival was observed when cells were pre-incubated with trehalose and serum in the 248 
presence of PP-50 (64 ± 3 %), as measured by trypan blue staining. A significant disparity in 249 
cryosurvival was observed between both methods used. 250 
 251 
4. Discussion 252 
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  253 
In this study, the effect of PP-50 on trehalose uptake was analysed in SAOS-2 cells. 254 
Analysis by confocal microscopy, quantification of colocalisation, and cryopreservation, all 255 
showed that incubation with PP-50 induced the transport of trehalose across the cell 256 
membrane resulting in increased cryosurvival of osteosarcoma cells. 257 
 258 
Confocal microscopy was used to investigate labelled trehalose uptake mediated by PP-50 259 
on osteosarcoma cells (Fig. 1). Labelled trehalose diffused across cell membranes only in 260 
the presence of PP-50, demonstrating the polymer’s ability to transport hydrophilic 261 
molecules across the cell membrane. Propidium iodide, a non-permeable dye, was used to 262 
assess cell viability as it is not taken up by living cells [34,35]. This dye was utilised after 263 
incubation with PP-50 and trehalose to confirm that trehalose uptake was due to polymer 264 
transport and not cell permeability caused by polymer cytotoxicity. Lack of propidium iodide 265 
staining confirmed PP-50 mediated transport and suggested the absence of noticeable 266 
apoptosis and necrosis. This is in agreement with previous studies regarding the 267 
biocompability of PP-50, where higher concentrations of the polymer showed no negative 268 
effect on osteosarcoma cells [22].  269 
 270 
To investigate the trafficking of trehalose and PP-50 across the cell membrane, 271 
colocalisation of labelled trehalose and polymer was accomplished using confocal 272 
microscopy (Fig. 2). As observed, the majority of labelled molecules localised jointly within 273 
the perinuclear area. This area is located next to the cell nucleus and contiguous with the 274 
lumen of the endoplasmic reticulum, where most delivery system agents are targeted [36]. 275 
As PP-50 was developed to mimic viral peptides that penetrate cell membranes, this is in 276 
agreement with the fate of most efficient DNA viruses that localise in this area to deposit 277 
their genomic DNA near the host nucleus [21,37,38]. A similar accumulation has been 278 
shown also for polyethylenimine (PEI), one of the most efficient non-viral gene transfer 279 
agents known, when used along DNA complexes [39]. This result highlights the use of PP-280 
50 as a drug delivery system. It is worth noticing that the labelling of trehalose and PP-50 281 
may have affected their physical properties and cell trafficking. The impact of this labelling 282 
will be the topic of future studies 283 
 284 
The trafficking of trehalose through the endolysosomal pathway was not investigated in this 285 
study. However, previous studies have shown that escaping the endolysosomal route is a 286 
process preceding the accumulation in the perinuclear area [39]. The fate of both the 287 
polymer and trehalose after being accumulated in the perinuclear area should be 288 
investigated in future studies. 289 
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 290 
Next, trehalose and PP-50 colocalisation was quantitatively analysed by using the Pearson 291 
and Manders coefficients. These coefficients show the fraction of trehalose colocalised with 292 
the polymer, and vary from 0 for non-overlapping images to 1 for complete colocalisation 293 
[40,41]. Both coefficients were close to 0.8, suggesting a high degree of colocalisation 294 
between trehalose and PP-50. Confocal visualisation and quantitative analysis of the 295 
colocalisation were in agreement, strongly indicating the direct involvement of PP-50 in the 296 
trafficking of trehalose across the cell membrane. 297 
 298 
A trehalose concentration of 200 mM was chosen for cryopreservation experiments, as 299 
previous studies have shown intracellular trehalose concentrations higher than 200 mM 300 
when cells were pre-incubated in the presence of PP-50 [26]. This concentration was higher 301 
than the one used in confocal microscopy, and was selected to ensure an intracellular 302 
concentration sufficient to provide freezing protection [2,42,43]. A labelled trehalose 303 
concentration of 50 mM was used for confocal analysis due to material limitation. 304 
 305 
In order to further analyse the impact of trehalose transport mediated by PP-50, cells were 306 
pre-incubated with trehalose, FBS or a combination of both molecules in the presence and 307 
absence of PP-50, and then cryopreserved (Fig. 3). The cytotoxicity of these molecules was 308 
previously investigated and no negative effect on cellular viability was observed [22]. As 309 
seen in the figure, a large disparity was observed between cryosurvival as measured by 310 
trypan blue staining and metabolic activity. A vast majority of cells alive according to the 311 
trypan blue staining were not confirmed with the MTS assay. Trypan blue is excluded from 312 
intact cells and the MTS assay depends on the activity of cell cytoplasmic esterases that are 313 
capable of degrading permeable MTS into formazan [44,45]. Since both methods rely 314 
exclusively on the permeability of lipid bilayers immediately after thawing, these assays may 315 
not be the most suitable options when cell membranes are transiently more stable due to the 316 
trehalose, proven to stabilise membrane components [46]. 317 
 318 
Other factors possibly involved in this discrepancy of cell cryosurvival include the limitations 319 
of both methods used to quantify cryosurvival. Although the trypan blue staining method is 320 
widely used to measure cell viability, it has been described as highly subjective and 321 
possessing significant accuracy errors in numerous studies [31,47]. Additionally, cell 322 
metabolism may have been undermined immediately after thawing in cells incubated with 323 
trehalose or FBS. True cryosurvival, i.e., cell growth, was not taken into account using either 324 
trypan blue staining or the MTS assay [48]. Cells with intact membranes that have initiated 325 
apoptotic pathways not manifested yet with the achievement of cell death were also not 326 
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considered. Normally, cell death is manifested hours after the cells are thawed through 327 
apoptosis or necrosis. Assessments conducted at different time points could give insights on 328 
the delayed decline in cell viability, a process often not detected immediately post-thawing 329 
[49]. Future work should aim to use an assay that considers both the capability of cells to 330 
duplicate and their ability to maintain cell properties after cryopreservation.  331 
 332 
The use of FBS in the pre-incubation media significantly increased the cryosurvival of 333 
osteosarcoma cells compared to pre-incubation media without it. This trend was even more 334 
pronounced when PP-50 was also present in the pre-incubation media. This highlights the 335 
role of FBS as an important source of proteins that may play a major role in cell 336 
cryopreservation when used along permeating agents such as PP-50. However, since FBS 337 
presents several disadvantages when used in biomedical applications, future work should 338 
aim at identifying effective substitutes for cryopreservation-promoting factors present in FBS. 339 
 340 
In this work, PP-50 has been shown to mediate the transport of trehalose, highlighting its 341 
use in existing cell cryopreservation protocols and therapeutic applications. 342 
 343 
5. Conclusions 344 
 345 
In this study, the cellular trafficking of labelled trehalose when using an amphipathic pH-346 
responsive biopolymer was studied. Intracellular trehalose loading in the presence of PP-50 347 
was shown by confocal microscopy. Quantitative analysis of colocalisation resulted in a high 348 
degree of colocalisation between the trehalose and polymer. Both molecules were shown to 349 
accumulate in the perinuclear area of cells, highlighting the use of PP-50 as a drug delivery 350 
system. Cryopreservation of cells incubated in the presence of trehalose and PP-50 showed 351 
increased cryosurvival rates as measured by trypan blue staining and metabolic activity. 352 
Further work is needed to determine the intracellular fate of trehalose and PP-50. This study 353 
provides an important step toward the use of amphipathic biopolymers for cryopreservation 354 
and biomedical applications. 355 
 356 
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List of Figures 510 
 511 
Figure 1: Confocal microscopy analysis of SAOS-2 cells incubated with labelled trehalose in 512 
the presence and absence of PP-50. Cells were incubated with for different periods of time 513 
with 50 mM of FITC-trehalose in the presence or absence of 250 µg/ml PP-50. After 514 
incubation, cells were stained with 5 µg/ml propidium iodide (red fluorescence) and 5 µg/ml 515 
Hoechst H33342 (blue fluorescence). Data are representative of a minimum of three 516 
separate experiments. Scale bar represents 30 µm.  517 
 518 
Figure 2: Colocalisation analysis of labelled PP-50 with labelled trehalose by confocal 519 
microscopy. Cells were incubated with 250 µg/ml PP-50/AF647 (red fluorescence) and 50 520 
mM FITC-trehalose (green fluorescence) for 4 hrs. Subsequently cells were stained with 5 521 
µg/ml Hoechst H33342 (blue fluorescence) for 15 min. Colocalisation is shown in yellow. 522 
Data are representative of a minimum of three separate experiments. Scale bar represents 523 
25 µm. 524 
 525 
Figure 3: Cryosurvival of SAOS-2 cells incubated with different media measured by trypan 526 
blue and the MTS assay. Error bars represent the standard deviation of three replicates. C(-) 527 
represents the negative control of freezing, i.e. untreated cells frozen in media composed of 528 
100 % (v/v) DMEM, whereas C(+) represents the positive control of freezing, i.e. untreated 529 
cells frozen in media composed of 90 % (v/v) DMEM and 10 % (v/v) Me2SO. Data were 530 
normalised to the positive control of freezing C(+). **P<0.01, ***P<0.001, ****P<0.0001.  531 
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